Foundation / Corporation
Israel Cancer Research Fund (ICRF), City of Hope (CoH) and The Harvey L. Miller Family Foundation
Grants to Israel and City of Hope, California investigators for collaborative basic or clinical research related to cancer. Funding is intended to advance cancer research and to help develop new diagnostic tools, life-saving protocols, and strategies for cancer prevention. This new collaborative grant mechanism is intended to promote international partnerships for outstanding cancer research in Israel with a collaborating investigator at City of Hope in Duarte, California.
The funds may be used to purchase needed reagents, cover the cost of animals or use of core facilities, as well as salary for technical support. Funds can also be used for the City of Hope collaborator to travel to Israel (economy class) or vice versa for a short-term visit related to the work in progress, and only during the grant award period.
Applications may propose to discover and inform about genetic signaling or biochemical pathway interactions or to describe novel mechanisms of tumorigenesis. Applications are not limited to these examples, but must propose novel approaches that are neither an extension, nor expansion, of currently funded projects. Unique "value added" by the collaboration of the applicant labs should be clearly articulated.
While not a requirement, grants that utilize interdisciplinary approaches and that are multi-investigator are encouraged.
Applications will be considered for funding on the basis of the overall merit of the proposal as determined by the Scientific Review Panel and the potential of the project to enhance the capacity of Israeli scientists to accomplish more in-depth studies or investigations of wider scope than would otherwise be possible. The complementary expertise of the labs involved in the partnership should be clearly articulated.
All grant proposals will be subject to rigorous peer review. Ideally, the investigators in the two collaborating institutions will have mutual research interests, but complementary approaches. The application should detail what work will be performed in which site and how the data generated at each site will be integrated into a unified program. In the best of all worlds, successful outcome can be measured in co-authorships in high-profile journals.
GrantWatch ID#: 171771
The program will support approximately three grants for two (2) years at a level of $150,000 per year per team ($300,000 total). The support to the participating institutions will be divided such that 50% of the funds will be designated for the Israeli investigator and institution, and 50% for the City of Hope investigator.
Grants will be awarded for a period of two years.
The application must originate from an Israeli scientist/institution, who will be designated as the principal investigator, and one City of Hope investigator who will be considered as the co-principal investigator. All additional collaborating investigators/institutions, whether in Israel or in North America, will be considered as co-investigators. The Israeli institutions are not permitted to utilize ICRF funds for overhead or other indirect costs.
Specific Eligibility Criteria for Israeli Scientists:
ICRF funds for cancer research are available to citizens of Israel, both native-born and those who have settled there. Funds are not available to visiting scientists. (Proof of Israeli citizenship must be furnished upon request.)
In no case are the funds to be used by the Israeli collaborator to relocate out of Israel for an extended period of time.
Only one grant application per Israeli principal investigator will be accepted for each submission deadline.
Timetable for the Awarding of Grants:
- Received by the Fund in New York: January 7, 2019
- Notification of Decision: July 1, 2019
- Activation of Award: Sept. 1, 2019
CV format: https://grants.nih.gov/grants/forms/biosketch.htm
For a list of participating City of Hope faculty, please visit the following website: http://www.cityofhope.org/cancer-research-scholars-program.
Safeguarding the rights and welfare of human subjects involved in activities supported by the ICRF, as well as consideration of potential biohazards, is the responsibility of the institution(s) that received the award. Awards for projects involving human subjects and/or animals require prior review and approval by the appropriate institutional committee.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Please submit your application as an email attachment to: email@example.com.
Ellen T. Rubin
ICRF International Executive Office
295 Madison Avenue, Suite 1030
New York, NY 10017
USA: California: City of Hope